Companies Alphatec Holdings, Inc.
Alphatec (ATEC): executive pay, fiscal 2025
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Alphatec Holdings, Inc.’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers67th pct.Of 20 peer CEOs
CEO pay, last three years
- $9,477,979FY2023
- $6,221,699FY2024
- $10,260,507FY2025
CEO total pay was $10,260,507 in fiscal 2025, up from $6,221,699 in fiscal 2024.
FY2025: salary $762,000 · bonus $0 · stock awards $8,859,650 · option awards $0
Executives and directors
Craig Hunsaker · EVPJ. Todd Koning · CFOPatrick Miles · CEOScott Lish · COODavid Sponsel · EVPDavid Demski · Independent DirectorDavid Pelizzon · Independent DirectorKaren McGinnis · Independent DirectorKeith Valentine · Independent DirectorMortimer Berkowitz · Independent DirectorQuentin Blackford · Independent DirectorWard Woods · Independent Director
Frequently asked questions
Who was the highest-paid executive at Alphatec Holdings, Inc. in fiscal 2025?
As disclosed, Patrick Miles (President, Chairman and Chief Executive Officer) was the highest-paid executive at Alphatec Holdings, Inc. in fiscal 2025, with total compensation of $10,260,507.
How does Alphatec Holdings, Inc.'s chief executive pay compare to its disclosed peer group?
As disclosed, Patrick Miles's total compensation ranked at the 67th percentile of Alphatec Holdings, Inc.'s disclosed peer group.
What is Alphatec Holdings, Inc.'s CEO-to-median employee pay ratio?
As disclosed, Alphatec Holdings, Inc.'s CEO-to-median employee pay ratio was 77.8:1.
How did shareholders vote on Alphatec Holdings, Inc.'s executive compensation?
As disclosed, 86.84% of shareholders supported Alphatec Holdings, Inc.'s executive compensation in the latest say-on-pay vote.
How much does Alphatec Holdings, Inc. spend in total on board compensation for fiscal 2025?
As disclosed, Alphatec Holdings, Inc. reported total board compensation of $1,642,409 for fiscal 2025.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Patrick Miles | $762,000 | $0 | $8,859,650 | $0 | $600,000 | $0 | $38,857 | $10,260,507 |
| President, Chairman and Chief Executive Officer | ||||||||
| Craig Hunsaker | 498,625 | 0 | 4,515,970 | 0 | 257,500 | 0 | 1,047,777 | 6,319,872 |
| Executive Vice President, People & Culture | ||||||||
| Scott Lish | 485,009 | 0 | 4,494,154 | 0 | 257,500 | 0 | 34,582 | 5,271,245 |
| Chief Operating Officer | ||||||||
| David Sponsel | 445,390 | 0 | 3,024,662 | 0 | 450,000 | 0 | 34,355 | 3,954,407 |
| Executive Vice President, Sales | ||||||||
| J. Todd Koning | 480,775 | 0 | 3,062,444 | 0 | 250,000 | 0 | 36,656 | 3,829,875 |
| Executive Vice President and Chief Financial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Patrick Miles | $10,260,507 | $6,221,699 | $9,477,979 | ↑ +4,038,808 |
| Craig Hunsaker | 6,319,872 | 3,417,233 | 4,569,021 | ↑ +2,902,639 |
| Scott Lish | 5,271,245 | 2,575,871 | 2,585,149 | ↑ +2,695,374 |
| David Sponsel | 3,954,407 | 2,803,029 | 3,214,860 | ↑ +1,151,378 |
| J. Todd Koning | 3,829,875 | 2,616,961 | 3,360,339 | ↑ +1,212,914 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Compensation Committee designs executive compensation to attract, motivate, and retain highly qualified executives, aligning their interests with those of stockholders through a mix of cash and equity-based incentives.
| CEO STI target (% of salary) | 100% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | Compensia |
| Clawback policy | true |
| Anti-hedging | — |
| Anti-pledging | True |
Equity grants and outstanding awards
Grants of plan-based awards — fiscal year 2025
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| David Sponsel | RSU | 2025-06-11 | — | — | 3,866 | — | $45,348 |
| J. Todd Koning | RSU | 2025-01-29 | — | — | 133,920 | — | 1,615,075 |
| J. Todd Koning | RSU | 2025-06-11 | — | — | 20,929 | — | 245,497 |
| Scott Lish | RSU | 2025-06-11 | — | — | 21,751 | — | 255,139 |
| Patrick Miles | RSU | 2025-01-29 | — | — | 389,195 | — | 4,693,692 |
| Craig Hunsaker | RSU | 2025-06-11 | — | — | 21,751 | — | 255,139 |
| Patrick Miles | RSU | 2025-06-11 | — | — | 16,475 | — | 193,252 |
| Craig Hunsaker | RSU | 2025-01-29 | — | — | 195,126 | — | 2,353,220 |
| Scott Lish | PSU | 2025-01-29 | — | 173,417 | — | 346,834 | 2,091,409 |
| David Sponsel | PSU | 2025-01-29 | — | 114,322 | — | 228,644 | 1,378,723 |
| J. Todd Koning | PSU | 2025-01-29 | — | 114,322 | — | 228,644 | 1,378,723 |
| Scott Lish | RSU | 2025-01-29 | — | — | 193,317 | — | 2,331,403 |
| Patrick Miles | PSU | 2025-01-29 | — | 340,955 | — | 681,910 | 4,111,917 |
| David Sponsel | RSU | 2025-01-29 | — | — | 135,428 | — | 1,633,262 |
| Craig Hunsaker | PSU | 2025-01-29 | — | 173,417 | — | 346,834 | 2,091,409 |
Vehicle mix — grant-date fair value by award type
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| David Sponsel | $1,678,610 | $1,378,723 | $0 | 45.1% |
| J. Todd Koning | 1,860,572 | 1,378,723 | 0 | 42.6% |
| Scott Lish | 2,586,542 | 2,091,409 | 0 | 44.7% |
| Patrick Miles | 4,886,944 | 4,111,917 | 0 | 45.7% |
| Craig Hunsaker | 2,608,359 | 2,091,409 | 0 | 44.5% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
Outstanding equity awards at fiscal year-end 2025
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Scott Lish | RSU | 16,527 | — | $347,728 |
| David Sponsel | RSU | 20,007 | — | 420,947 |
| J. Todd Koning | RSU | 21,164 | — | 445,291 |
| Scott Lish | RSU | 21,164 | — | 445,291 |
| J. Todd Koning | RSU | 21,385 | — | 449,940 |
| David Sponsel | RSU | 23,375 | — | 491,810 |
| Scott Lish | PSU | 25,041 | — | 118,194 |
| Craig Hunsaker | RSU | 27,460 | — | 577,758 |
| David Sponsel | PSU | 30,314 | — | 143,082 |
| Craig Hunsaker | RSU | 30,475 | — | 641,194 |
| J. Todd Koning | PSU | 32,403 | — | 152,942 |
| Scott Lish | PSU | 33,388 | — | 702,484 |
| David Sponsel | PSU | 40,418 | — | 850,395 |
| J. Todd Koning | PSU | 43,204 | — | 909,012 |
| Craig Hunsaker | PSU | 46,175 | — | 217,946 |
| Patrick Miles | RSU | 54,529 | — | 1,147,290 |
| Craig Hunsaker | PSU | 61,566 | — | 1,295,349 |
| Patrick Miles | RSU | 68,238 | — | 1,435,728 |
| J. Todd Koning | PSU | 80,635 | — | 1,696,553 |
| Scott Lish | PSU | 80,635 | — | 1,696,553 |
| David Sponsel | PSU | 89,060 | — | 1,873,819 |
| Patrick Miles | PSU | 103,391 | — | 488,006 |
| Craig Hunsaker | PSU | 104,622 | — | 2,201,257 |
| J. Todd Koning | RSU | 114,322 | — | 2,405,335 |
| J. Todd Koning | PSU | 114,322 | — | 2,405,335 |
| David Sponsel | RSU | 114,322 | — | 2,405,335 |
| David Sponsel | PSU | 114,322 | — | 2,405,335 |
| Patrick Miles | PSU | 137,854 | — | 2,900,448 |
| Craig Hunsaker | RSU | 173,417 | — | 3,648,694 |
| Craig Hunsaker | PSU | 173,417 | — | 3,648,694 |
| Scott Lish | RSU | 173,417 | — | 3,648,694 |
| Scott Lish | PSU | 173,417 | — | 3,648,694 |
| Patrick Miles | PSU | 207,755 | — | 4,371,163 |
| Patrick Miles | RSU | 340,955 | — | 7,173,693 |
| Patrick Miles | PSU | 340,955 | — | 7,173,693 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Karen McGinnisIndependent · Audit Committee (Chair) · Compensation Committee (Chair) | $72,500 | $177,487 | — | — | — | $249,987 |
| Mortimer BerkowitzIndependent · Audit Committee · Nominating and Corporate Governance Committee (Chair) · Compensation Committee | 65,000 | 177,487 | — | — | — | 242,487 |
| Quentin BlackfordIndependent · Audit Committee · Compensation Committee | 62,500 | 177,487 | — | — | — | 239,987 |
| Ward WoodsIndependent · Compensation | 60,000 | 177,487 | — | — | — | 237,487 |
| Keith ValentineIndependent · Nominating and Corporate Governance Committee | 50,000 | 177,487 | — | — | — | 227,487 |
| David DemskiIndependent · Audit · Compensation | 45,000 | 177,487 | — | — | — | 222,487 |
| David PelizzonIndependent | 45,000 | 177,487 | — | — | — | 222,487 |
| Patrick MilesEmployee director · Audit · Nominating and Corporate Governance · Compensation | — | — | — | — | — | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $45,000 |
|---|---|
| Annual equity retainer | $185,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 15,000 / 10,000 |
| Stock ownership guideline | $135,000 |
Total cost of the board
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $400,000 |
| Equity awards (grant-date value) | $1,242,409 |
| All other compensation | $0 |
| Total cost of the board | $1,642,409 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Alphatec as a peer
Companies that benchmark against ATEC
21 companies name ATEC as a compensation peer
The list of companies that name ATEC as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2025
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
NVRO NevroDOCS DoximityTXG 10x GenomicsTACT Tactile Systems TechnologyTRCE Treace Medical ConceptsZYNX ZynexLMAT LeMaitre VascularAAT STAAR SurgicalTNDM Tandem Diabetes CareTMDX TransMedics GroupGKOS GlaukosNVCR NovoCureAORT ArtivionLIVN LivaNovaIRTC iRhythm TechnologiesPGC Paragon 28ATRC AtriCureINSP Inspire Medical SystemsMRVI Maravai Life Sciences HoldingsOCS OraSure Technologies
Peer reciprocity
The companies Alphatec Holdings, Inc. names as compensation peers that name it back in their own disclosed peer groups.
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Doximity | 2026 | Jeff Tangney | $627,000 | $18,955,899 | $0 | $0 | $19,586,169 |
| 2 | NovoCure | 2025 | Ashley Cordova | 901,837 | 8,249,965 | 2,752,814 | 811,653 | 13,198,354 |
| 3 | Glaukos | 2025 | Thomas Burns | 850,000 | 7,649,947 | 3,527,497 | 0 | 12,034,087 |
| 4 | Nevro | 2023 | Kevin Thornal | 515,625 | 10,080,173 | 0 | 402,750 | 11,453,548 |
| 5 | iRhythm Technologies | 2025 | Quentin Blackford | 700,003 | 8,919,457 | 0 | 1,350,000 | 11,003,163 |
| 6 | TransMedics Group | 2025 | Waleed Hassanein | 776,923 | 4,364,013 | 4,360,147 | 1,400,000 | 10,915,533 |
| 7 | Alphatec Holdings, Inc. | 2025 | Patrick Miles | 762,000 | 8,859,650 | 0 | 600,000 | 10,260,507 |
| 8 | Maravai Life Sciences Holdings | 2025 | Bernd Brust | 388,863 | 7,660,000 | 1,460,000 | 425,343 | 10,129,708 |
| 9 | AtriCure | 2025 | Michael Carrel | 828,439 | 7,203,478 | 0 | 1,171,703 | 9,217,620 |
| 10 | LivaNova | 2025 | Vladimir Makatsaria | 956,115 | 4,303,092 | 1,374,999 | 1,287,656 | 8,047,217 |
| 11 | Inspire Medical Systems | 2025 | Timothy Herbert | 750,572 | 5,999,655 | 0 | 961,557 | 7,711,784 |
| 12 | Artivion | 2025 | J. Patrick Mackin | 835,145 | 5,006,990 | 0 | 991,368 | 6,883,108 |
| 13 | Tandem Diabetes Care | 2025 | John Sheridan | 790,583 | 5,367,796 | 0 | 674,090 | 6,858,503 |
| 14 | 10x Genomics | 2025 | Serge Saxonov | 674,250 | 5,020,269 | 0 | 634,725 | 6,329,244 |
| 15 | Staar Surgical | 2025 | Adam Wyll | 750,000 | 2,228,916 | 0 | 952,500 | 4,806,038 |
| 16 | LeMaitre Vascular | 2025 | George LeMaitre | 806,347 | 1,050,000 | 1,050,000 | 680,015 | 3,780,990 |
| 17 | Paragon 28 | 2025 | Douglas Kennedy | 936,000 | 863,540 | 0 | 1,205,341 | 3,479,531 |
| 18 | Tactile Systems Technology | 2025 | John Dillon | 618,000 | 395,824 | 0 | 319,300 | 1,344,093 |
| 19 | Zynex | 2024 | Thomas Sandgaard | 700,000 | 112,458 | 0 | 170,625 | 991,810 |
| — | Treace Medical Concepts | — | — | — | — | — | — | not in coverage universe |
| — | OraSure Technologies | — | — | — | — | — | — | not in coverage universe |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Alphatec Holdings, Inc. | 157% | PSU 50 · RSU 50 | No | Compensia |
| 10x Genomics | 93% | PSU 60 · RSU 40 | Yes — 3-year Relative TSR | Alpine Rewards LLC |
| Artivion | 118.7% | PSU 50 · RSU 50 | No | Willis Towers Watson |
| AtriCure | not disclosed | PSU 70 · RSU 30 | No | Korn Ferry |
| Doximity | not disclosed | not disclosed | No | Aon plc (Human Capital Solutions Practice) |
| Glaukos | not disclosed | RSU 50 · PRSU 50 | No | Frederic W. Cook & Co., Inc. |
| Inspire Medical Systems | 111.4% | PSU 50 · RSU 50 | No | Aon |
| iRhythm Technologies | 173% | RSU 50 · PSU 50 | Yes — Relative TSR | Aon and Mercer |
| LeMaitre Vascular | not disclosed | Option 50 · RSU 25 · PSU 25 | No | not disclosed |
| LivaNova | 122.4% | PSU 50 · RSU 25 · Options 25 | No | Pearl Meyer |
| Maravai Life Sciences Holdings | not disclosed | not disclosed | No | Meridian Compensation Partners, LLC |
| Nevro | 53.7% | not disclosed | No | Aon |
| NovoCure | 100% | PSU 50 · RSU 25 · Options 25 | No | Frederic W. Cook & Co., Inc. |
| OraSure Technologies | not disclosed | not disclosed | not disclosed | not disclosed |
| Paragon 28 | 120% | RSU 100 | Yes — TSR | Aon |
| Staar Surgical | 191% | PSU 100 | Yes — Relative Total Shareholder Return (TSR) vs. S&P 600 Real Estate Index | not disclosed |
| Tactile Systems Technology | not disclosed | RSU 50 · PSU 50 | not disclosed | Compensation Advisory Partners (CAP) |
| Tandem Diabetes Care | 87% | PSU 50 · RSU 50 | Yes — TSR performance compared to the Russell 3000 index in the three-year period between 2025 and 2027 | WTW |
| TransMedics Group | 175% | Options 50 · RSU 50 | not disclosed | Pearl Meyer |
| Treace Medical Concepts | not disclosed | not disclosed | not disclosed | not disclosed |
| Zynex | not disclosed | not disclosed | not disclosed | not disclosed |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-10 | 81,927,395 | 12,420,476 | 293,219 | 86.84% | Passed |
| 2025 | 2025-06-11 | 82,619,803 | 6,064,612 | 65,969 | 93.16% | Passed |
| 2024 | 2024-06-12 | 69,776,291 | 12,628,164 | 49,825 | 84.68% | Passed |
| 2023 | 2023-06-14 | 56,507,999 | 728,685 | 30,493 | 98.73% | Passed |
| 2022 | 2022-06-15 | 37,605,393 | 18,739,526 | 356,643 | 66.74% | Passed |
| 2021 | 2021-06-16 | 55,107,427 | 3,693,015 | 591,634 | 93.72% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2026 | 2026-06-10 | 86.84%a |
| 2025 | 2025-06-11 | 93.16%b |
| 2024 | 2024-06-12 | 84.68%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 77.8 : 1 |
|---|---|
| CEO total compensation | $10,260,507 |
| Median employee compensation | $131,967 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2025 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| Keith Valentine | Director | 2026-05-07 | A | 56,153 | $7 | $420,586 | Common | Form 4 ↗ |
| Keith Valentine | Director | 2026-05-08 | A | 43,847 | 8 | 330,606 | Common | Form 4 ↗ |
| Keith Valentine | Director | 2026-05-11 | A | 35,000 | 7 | 245,000 | Common | Form 4 ↗ |
| Mortimer Berkowitz | Director | 2026-06-10 | A | 32,012 | 0 | 0 | Common | Form 4 ↗ |
| David Pelizzon | Director | 2026-06-10 | A | 32,012 | 0 | 0 | Common | Form 4 ↗ |
| Quentin Blackford | Director | 2026-06-10 | A | 32,012 | 0 | 0 | Common | Form 4 ↗ |
| Karen McGinnis | Director | 2026-06-10 | A | 32,012 | 0 | 0 | Common | Form 4 ↗ |
| David Demski | Director | 2026-06-10 | A | 32,012 | 0 | 0 | Common | Form 4 ↗ |
| Keith Valentine | Director | 2026-06-10 | A | 32,012 | 0 | 0 | Common | Form 4 ↗ |
| Karen McGinnis | Director | 2026-06-11 | D | 6,050 | 8 | 48,461 | Common | Form 4 ↗ |
| Tyson Eliot Marshall | General Counsel & Corp. SEC. | 2026-08-05 | D | 8,168 | 10 | 78,821 | Common | Form 4 ↗ |
| Patrick Miles | Director | 2026-09-10 | A | 115,000 | 9 | 1,013,150 | Common | Form 4 ↗ |
| Thomas Andrew Carls | EVP, Data & Imaging Solutions | 2026-10-05 | A | 200,000 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (72 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Patrick Miles. DEF 14A, filed 2026-04-29. Section “2025 Summary Compensation Table” · page 51. As printed: 10,260,507. View filing ↗
- Section 01, Craig Hunsaker. DEF 14A, filed 2026-04-29. Section “2025 Summary Compensation Table”. As printed: 6,319,872. View filing ↗
- Section 01, Scott Lish. DEF 14A, filed 2026-04-29. Section “2025 Summary Compensation Table”. As printed: 5,271,245. View filing ↗
- Section 01, David Sponsel. DEF 14A, filed 2026-04-29. Section “2025 Summary Compensation Table”. As printed: 3,954,407. View filing ↗
- Section 01, J. Todd Koning. DEF 14A, filed 2026-04-29. Section “2025 Summary Compensation Table”. As printed: 3,829,875. View filing ↗
- Section 03, David Sponsel RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, J. Todd Koning RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, J. Todd Koning RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Scott Lish RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Patrick Miles RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Craig Hunsaker RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Patrick Miles RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Craig Hunsaker RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Scott Lish PSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, David Sponsel PSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, J. Todd Koning PSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Scott Lish RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Patrick Miles PSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, David Sponsel RSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 03, Craig Hunsaker PSU. DEF 14A, filed 2026-04-29. Section “Grants of Plan-Based Awards” · grants of plan-based awards table. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2026-04-29. Section “CEO Pay Ratio”. As printed: 77.8 : 1. View filing ↗
- Section 08, Karen McGinnis. DEF 14A, filed 2026-04-29. Section “Director Compensation”. As printed: 249,987. View filing ↗
- Section 08, Mortimer Berkowitz. DEF 14A, filed 2026-04-29. Section “Director Compensation”. As printed: 242,487. View filing ↗
- Section 08, Quentin Blackford. DEF 14A, filed 2026-04-29. Section “Director Compensation”. As printed: 239,987. View filing ↗
- Section 08, Ward Woods. DEF 14A, filed 2026-04-29. Section “Director Compensation”. As printed: 237,487. View filing ↗
- Section 08, Keith Valentine. DEF 14A, filed 2026-04-29. Section “Director Compensation”. As printed: 227,487. View filing ↗
- Section 08, David Demski. DEF 14A, filed 2026-04-29. Section “Director Compensation”. As printed: 222,487. View filing ↗
- Section 08, David Pelizzon. DEF 14A, filed 2026-04-29. Section “Director Compensation”. As printed: 222,487. View filing ↗
- Section 08, Patrick Miles. DEF 14A, filed 2026-04-29. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, Keith Valentine 2026-05-07. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Keith Valentine 2026-05-08. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Keith Valentine 2026-05-11. Form 4, filed 2026-05-11. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Mortimer Berkowitz 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Pelizzon 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Quentin Blackford 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Karen McGinnis 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, David Demski 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Keith Valentine 2026-06-10. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Karen McGinnis 2026-06-11. Form 4, filed 2026-06-12. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Tyson Eliot Marshall 2026-08-05. Form 4, filed 2026-08-07. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Patrick Miles 2026-09-10. Form 4, filed 2026-09-10. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Thomas Andrew Carls 2026-10-05. Form 4, filed 2026-10-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2026 vote. Form 8-K, filed 2026-06-11. Item 5.07 · say-on-pay result. As reported: 86.84% (votes for as printed: 81,927,395). View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-06-13. Item 5.07 · say-on-pay result. As reported: 93.16% (votes for as printed: 82,619,803). View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-06-17. Item 5.07 · say-on-pay result. As reported: 84.68% (votes for as printed: 69,776,291). View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
- Section 09b board cost (computed). Computed. Cash 400,000 + equity 1,242,409 + all other 0 = 1,642,409, summed across the director compensation table rows.
- Doximity, Section 10b CEO total. DEF 14A, filed 2026-07-15. CEO total compensation as printed in Doximity's own proxy. As printed: 19,586,169. View filing ↗
- NovoCure, Section 10b CEO total. DEF 14A, filed 2026-04-20. CEO total compensation as printed in NovoCure's own proxy. As printed: 13,198,354. View filing ↗
- Glaukos, Section 10b CEO total. DEF 14A, filed 2026-04-16. CEO total compensation as printed in Glaukos's own proxy. As printed: 12,034,087. View filing ↗
- Nevro, Section 10b CEO total. DEF 14A, filed 2024-04-12. CEO total compensation as printed in Nevro's own proxy. As printed: 11,453,548. View filing ↗
- iRhythm Technologies, Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in iRhythm Technologies's own proxy. As printed: 11,003,163. View filing ↗
- TransMedics Group, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in TransMedics Group's own proxy. As printed: 10,915,533. View filing ↗
- Alphatec Holdings, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in Alphatec Holdings, Inc.'s own proxy. As printed: 10,260,507. View filing ↗
- Maravai Life Sciences Holdings, Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in Maravai Life Sciences Holdings's own proxy. As printed: 10,129,708. View filing ↗
- AtriCure, Section 10b CEO total. DEF 14A, filed 2026-04-06. CEO total compensation as printed in AtriCure's own proxy. As printed: 9,217,620. View filing ↗
- LivaNova, Section 10b CEO total. DEF 14A, filed 2026-04-29. CEO total compensation as printed in LivaNova's own proxy. As printed: 8,047,217. View filing ↗
- Inspire Medical Systems, Section 10b CEO total. DEF 14A, filed 2026-03-20. CEO total compensation as printed in Inspire Medical Systems's own proxy. As printed: 7,711,784. View filing ↗
- Artivion, Section 10b CEO total. DEF 14A, filed 2026-04-01. CEO total compensation as printed in Artivion's own proxy. As printed: 6,883,108. View filing ↗
- Tandem Diabetes Care, Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Tandem Diabetes Care's own proxy. As printed: 6,858,503. View filing ↗
- 10x Genomics, Section 10b CEO total. DEF 14A, filed 2026-04-24. CEO total compensation as printed in 10x Genomics's own proxy. As printed: 6,329,244. View filing ↗
- Staar Surgical, Section 10b CEO total. DEF 14A, filed 2026-04-10. CEO total compensation as printed in Staar Surgical's own proxy. As printed: 4,806,038. View filing ↗
- LeMaitre Vascular, Section 10b CEO total. DEF 14A, filed 2026-04-14. CEO total compensation as printed in LeMaitre Vascular's own proxy. As printed: 3,780,990. View filing ↗
- Paragon 28, Section 10b CEO total. DEF 14A, filed 2026-03-16. CEO total compensation as printed in Paragon 28's own proxy. As printed: 3,479,531. View filing ↗
- Tactile Systems Technology, Section 10b CEO total. DEF 14A, filed 2026-04-13. CEO total compensation as printed in Tactile Systems Technology's own proxy. As printed: 1,344,093. View filing ↗
- Zynex, Section 10b CEO total. DEF 14A, filed 2025-03-28. CEO total compensation as printed in Zynex's own proxy. As printed: 991,810. View filing ↗
- Section 10a, Nevro reciprocity. DEF 14A. Nevro names Alphatec Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Zynex reciprocity. DEF 14A. Zynex names Alphatec Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Artivion reciprocity. DEF 14A. Artivion names Alphatec Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, iRhythm Technologies reciprocity. DEF 14A. iRhythm Technologies names Alphatec Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, AtriCure reciprocity. DEF 14A. AtriCure names Alphatec Holdings, Inc. in its own disclosed peer group (read from its most recent proxy). View filing ↗